Condition: Acute Respiratory Failure · Sponsor: Université NAZI BONI
Acute respiratory failure (ARF) is a frequent medical emergency, involving high costs for health organizations and patients who often require intensive care and respiratory assistance. According to an international study, 61% of hypoxemic patients in intensive care receive invasive ventilation \[3\]. Invasive mechanical ventilation is often unavailable in low-income countries and non-invasive ventilatory supports such as continuous positive airway pressure (CPAP) and high-flow oxygen therapy (HFO) were very useful during the COVID-19 pandemic. They reduced the rate of intubation and ICU admissions. In addition, CPAP can be used without a ventilator, no electricity is required. So, it could be a support of choice in low-income countries. Used of Boussignac-type CPAP could potentially reduce the recourse to intubation in patients with acute hypoxemic respiratory failure in a context where access to invasive ventilation remains very limited.
This description comes directly from the study's public registry record.
Ismael Guibla, doctor · +22676135113 · ismaelguibla@gmail.com
Ibrahim Alain Traore, professor · +22671457580 · itraore80@gmail.com
Always discuss trial participation with your own doctor first.
| Centre Hospitalier Universitaire Souro Sanou | Bobo-Dioulasso, Houet, Burkina Faso | Recruiting |
| CHU Yalgado Ouedraogo | Ouagadougou, Kadiogo, Burkina Faso | Not Yet Recruiting |
| CHU Tengandogo | Ouagadougou, Kadiogo, Burkina Faso | Not Yet Recruiting |
| CHU Bogodogo | Ouagadougou, Kadiogo, Burkina Faso | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06912360